What is the objective of this study?
This study is designed to test the safety and efficacy of beginning TTFields Treatment together with RT and TMZ therapy for newly diagnosed GBM patients. [The Trident Trial].
How can I take part in the TRIDENT trial?
Does the randomization process mean I may not receive treatment?
No. All patients will receive the standard of care. This means both arms will receive the Optune System. Please see our Trial information for more detail. [TRIDENT Trial]
Do I need to carry the device all the time?
The system and the portable battery weigh about 1.3 kilograms, or 2.7 pounds, altogether and can be carried in a dedicated shoulder bag or backpack when walking around. Patients may not necessarily be physically carrying the system most of the time, but will rather use it while it is continuously placed in one location (e.g. on a desk, a table or on the floor inside the carrying bag). The system was designed to allow the performance of normal daily routines.
Will the use of TTFields pose any risk to family members or other people?
The use of the device will not interfere with household or standard personal electronic devices. There is no exposure of TTFields to non-users, such as co-workers and family members.
How will the device affect my social life?
The device was designed to allow patients to continue with daily routines. You can wear head covers, such as a loose weave wig, headscarf, or a loose-fitting hat that allows for airflow to conceal the transducer arrays, and you may place the array wires underneath your clothes. Novocure will offer help and support related to appearance issues if you are using TTFields. For additional information, please see Living with TTFields.